QuiVad

Home / Funds / Voleon Capital Management LP

Voleon Capital Management LP

The short positions this fund discloses today, across every market.

Follow

Open short positions, the heaviest first.
IssuerMarket% of capitalSince
Zealand Pharma A/SDenmark1.11%May 19, 2026
B&M European Value Retail S.A.Germany0.79%April 20, 2026
Oryzon Genomics, S.A.Spain0.63%July 3, 2026
Gubra A/SDenmark0.59%March 23, 2026
Lang & Schwarz AktiengesellschaftGermany0.59%February 2, 2022
Tubacex, S.A.Spain0.59%June 30, 2026
Medigene AGGermany0.55%December 4, 2017
Atos GroupFrance0.50%July 21, 2026

History of disclosures

6109 disclosures on record for this fund.
DateIssuerMarket% of capitalEnd of publication
April 12, 2023Nokian RenkaatFinland0.76%still open
April 6, 2023Hansa Biopharma ABSweden0.53%still open
April 5, 2023Fugro N.V.Netherlands0.58%still open
April 5, 2023Zealand Pharma A/SDenmark0.45%April 5, 2023
April 4, 2023Zealand Pharma A/SDenmark0.50%April 4, 2023
April 4, 2023Saipem SPAItaly0.33%still open
April 3, 2023EuroapiFrance0.70%July 3, 2023
March 30, 2023Nokian RenkaatFinland0.80%still open
March 30, 2023Saipem SPAItaly0.68%still open
March 30, 2023Laboratorios Farmaceuticos Rovi, S.A.Spain0.47%still open
March 28, 2023Laboratorios Farmaceuticos Rovi, S.A.Spain0.51%still open
March 27, 2023QT GroupFinland0.49%still open
March 23, 2023Nokian RenkaatFinland0.79%still open
March 21, 2023Hansa Biopharma ABSweden0.50%still open
March 20, 2023Nokian RenkaatFinland0.81%still open
March 17, 2023EuroapiFrance0.61%July 3, 2023
March 17, 2023Fugro N.V.Netherlands0.61%still open
March 15, 2023Nokian RenkaatFinland0.70%still open
March 14, 2023Nokian RenkaatFinland0.66%still open
March 13, 2023Saipem SPAItaly0.84%still open
March 10, 2023Fugro N.V.Netherlands0.54%still open
March 10, 2023EuroapiFrance0.52%July 3, 2023
March 10, 2023Nokian RenkaatFinland0.50%still open
March 8, 2023Saipem SPAItaly0.70%still open
March 7, 2023Fugro N.V.Netherlands0.60%still open
March 3, 2023Saipem SPAItaly0.61%still open
March 1, 2023Oncopeptides ABSweden0.68%still open
March 1, 2023Solutions 30 SEFrance0.47%March 3, 2023
February 28, 2023QT GroupFinland0.51%still open
February 27, 2023Saipem SPAItaly0.55%still open
February 24, 2023Oncopeptides ABSweden0.76%still open
February 24, 2023Fugro N.V.Netherlands0.50%still open
February 22, 2023Laboratorios Farmaceuticos Rovi, S.A.Spain0.39%still open
February 21, 2023Oncopeptides ABSweden0.88%still open
February 21, 2023Laboratorios Farmaceuticos Rovi, S.A.Spain0.51%still open
February 17, 2023Oncopeptides ABSweden0.98%still open
February 15, 2023Oncopeptides ABSweden1.09%still open
February 8, 2023Oncopeptides ABSweden1.10%still open
February 6, 2023Solutions 30 SEFrance0.53%March 3, 2023
February 3, 2023Oncopeptides ABSweden1.09%still open
February 2, 2023Solutions 30 SEFrance0.48%February 6, 2023
January 30, 2023Sinch AB (publ)Sweden0.51%still open
January 24, 2023Oncopeptides ABSweden1.19%still open
January 19, 2023Oncopeptides ABSweden1.20%still open
January 18, 2023Oncopeptides ABSweden1.19%still open
January 11, 2023Oncopeptides ABSweden1.29%still open
January 11, 2023Sinch AB (publ)Sweden0.57%still open
January 10, 2023Solutions 30 SEFrance0.58%February 6, 2023
January 3, 2023Oncopeptides ABSweden1.38%still open
January 3, 2023Solutions 30 SEFrance0.67%February 6, 2023

The funds short on the same companies

Download as CSV

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Voleon Capital Management LP, data as at July 21, 2026, https://www.quivad.com/detenteur/voleon-capital-management-lp?page=29